Table 2.
Characteristics of the cohort comprising sJIA and “suspected” sJIA cohort
|
Characteristics |
sJIA (ie. fulfilling ILAR criteria) |
“suspected” sJIA |
Total cohort |
|---|---|---|---|
| n = 18 | n =13 | n = 31 | |
| Mean age (years) |
11.9 |
6.9** |
9.8 |
| Male:Female |
13:5 |
7:6NS |
20:11 |
| Mean duration of symptoms at time of presentation (days) |
109.1 |
51.8NS |
85.1 |
| Number of patients who received pre treatment with steroids |
8(44.4%) |
2(15.4%)NS |
10 |
| Mean daily dose of steroids (mg/kg/day)# |
0.96 |
2.47NS |
1.3 |
| Mean number of days that the patients had received steroids |
8.13 |
7.5NS |
8 |
| Number of patients who developed MAS on follow up |
1 |
6* |
7 |
| Average number of joints |
9 |
0* |
5.2 |
| Mean ESR(mm/hr) |
62.2 |
43.8** |
54.5 |
| Mean CRP (mg/L) |
130.5 |
116.2 NS |
124.2 |
| Mean Hemoglobin (gm/dL) |
10.9 |
10.2 NS |
10.6 |
| Mean WBC (cells x 109/L) |
15.2 |
20.7 NS |
17.5 |
| Mean platelet count (cells x 109/L) |
337.6 |
468.4 NS |
413.6 |
| Mean ALT (U/L) |
62.4 |
107.9 NS |
81.5 |
| Mean AST (U/L) | 55.5 | 41.3 NS | 49.5 |
*= p value <0.05, ** = p value < 0.005 ,NS = not significant.
# Mean value only of those patients who had been treated with steroids.